Position in ZTS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$444,114
-$373,590 QoQ
Shares Held
3,757
-42.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Polymer Capital Management (US) LLC holds $2,411,560 across 7 Drug Manufacturers - Specialty & Generic names. ZTS ranks #3 (18.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
6,290 | $828,644 | |
| 2 | VTRS |
Viatris Inc
|
33,324 | $450,207 | |
| 3 | ZTS |
Zoetis Inc.
This page
|
3,757 | $444,114 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
8,240 | $251,155 | |
| 5 | BIOA |
BioAge Labs, Inc.
|
11,688 | $204,423 | |
| 6 | BCRX |
Biocryst Pharmaceuticals Inc
|
21,353 | $203,280 | |
| 7 | AKBA |
Akebia Therapeutics, Inc.
|
21,394 | $29,737 |
All Filings in ZTS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $444,114 | 3,757 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $817,704 | 6,499 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $706,579 | 4,829 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $306,909 | 1,968 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||